Inovio Pharmaceuticals INO
NASDAQ INO
$1.16 -0.05 (-4.13%)
At close: Oct 2, 2026 · 4:00 PM EDT

Inovio Pharmaceuticals (INO) Depreciation and Depletion (2010 - 2026)

Updated

Inovio Pharmaceuticals (INO) reported Depreciation and Depletion of $322,034 for Q2 2026, down 9.6% from $356,151 a year earlier but up 1.6% from the prior quarter.

Analysis

Inovio Pharmaceuticals (INO) Depreciation and Depletion (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Inovio Pharmaceuticals' Depreciation and Depletion came in at $1.33 million, down 17.5% year-over-year; for FY2025, it came in at $1.42 million, down 21.2% from FY2024.

  • Depreciation and Depletion has declined for three consecutive years, with a five-year compound annual growth rate of -14.1% (FY2020 to FY2025).
  • By year, Depreciation and Depletion came in at $1.8 million in FY2024 (-31.3%), $2.62 million in FY2023 (-29.1%), $3.7 million in FY2022 (+21.7%) and $3.04 million in FY2021 (unchanged).
  • Five-year quarterly Depreciation and Depletion spans a low of $316,844 in Q1 2026 and a high of $945,200 in Q4 2021.
  • Year over year, Depreciation and Depletion has now declined in each of the last 15 quarters, with an average decline of 20.1% over the last eight quarters.
  • The high point for year-over-year Depreciation and Depletion in five years was Q1 2022 (growth of 40.7%); the low point was Q1 2024 (a decline of 40.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $316,844 (Q1 2026), $340,197 (Q4 2025) and $350,198 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Inovio Pharmaceuticals 94.68 Mn 94.68 Mn - 322,034.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 322,034.00
Mar 31, 2026 316,844.00
Dec 31, 2025 340,197.00
Sep 30, 2025 350,198.00
Jun 30, 2025 356,151.00
Mar 31, 2025 371,367.00
Dec 31, 2024 464,674.00
Sep 30, 2024 419,307.00
Jun 30, 2024 491,546.00
Mar 31, 2024 424,473.00
Dec 31, 2023 569,687.00
Sep 30, 2023 641,313.00
Jun 30, 2023 703,271.00
Mar 31, 2023 707,378.00
Dec 31, 2022 923,328.00
Sep 30, 2022 906,711.00
Jun 30, 2022 940,578.00
Mar 31, 2022 929,383.00
Dec 31, 2021 945,200.00
Sep 30, 2021 733,301.00
API Access

Inovio Pharmaceuticals Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=INO&period=max&api_key=YOUR_API_KEY